Paul G. Arnison, Ph.D. (Technology and Commercialization Advisor)
Dr. Arnison is a leading Canadian expert in biotechnology commercialization. He has developed intellectual property, participated in technology transfer and developed and grown small commercial enterprises for more than 30 years. He has experience as a commercial plant breeder and has established a new company for the development of haploidy and novel hybridization systems. Moreover, he has been involved in molecular farming and the use of plants as hosts for production of drugs and new bio-products. Most recently Dr. Arnison has been exploring novel technology for imaging using high energy x-ray neutron scattering technologies.
In 2003 Dr. Arnison founded Saponin Inc. as its President and Chief Scientific Officer. Previously he has served in various management capacities for start-up biotechnology companies: Paladin Hybrids, AAAHZ Inc., SynGene Biotek, Guardian Biotechnologies and AgriGenomics Inc. Dr. Arnison has been President of Botanical Alternatives Inc., a natural product consulting company, since 1993. Additionally, he has served as general manager of FARR Biotechnology Group, an agricultural biotechnology consulting company. He holds a B.Sc. in Biochemistry, and a Ph.D. in Plant Developmental Biology, 1974, from McGill University, Montreal, P.Q.